Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Fc epsilon RI Mouse anti-Human, Clone: IE7, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

$268.00 - $584.50

Specifications

Antigen Fc epsilon RI
Clone IE7
Dilution Flow Cytometry
Applications Flow Cytometry
Classification Monoclonal
View More Specs

Products 2
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
NB153963
SDP
View Documents
Novus Biologicals
NBP3120510.025MG
0.025 mg
Each for $268.00
Only null left
Add to Cart
 
NB153964
SDP
View Documents
Novus Biologicals
NBP3120510.2MG
0.2 mg
Each for $584.50
Only null left
Add to Cart
 
Description

Description

Fc epsilon RI Monoclonal antibody specifically detects Fc epsilon RI in Human samples. It is validated for Flow Cytometry
Specifications

Specifications

Fc epsilon RI
Flow Cytometry
Monoclonal
Mouse
Apoptosis, Asthma, Cancer, Immunology, Signal Transduction
PBS
2205
IgG1 κ
Protein A purified
IE7
Flow Cytometry
Unconjugated
RUO
Human
alpha polypeptide, Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide, Fc-epsilon RI-alpha, FcERI, high affinity immunoglobulin epsilon receptor alpha-subunit, high affinity immunoglobulin epsilon receptor subunit alpha, high-affinity, of mast cells, alpha polypeptide
Recombinant human protein, N-terminus.
Primary
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.